Cephalon All Financial Data in US $ (mln)
Worldwide  
  Overview  


EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.

Company Profile
Profile Cephalon (CEPH), is Pennsylvania based pharmaceutical company focused on neurological, CNS and Oncology related disorders.
Listed or Private Company Listed
Company Classification Biotechnology
Company Website Website

Full Company Profile Information

EventAnalyzer - Last Key Event
Closing Price DateClosing Price Date EventAnalyzer Note Market Cap (US $m) Change (%) Change (+$m)
7/28/2010 27 Jul [post market]: Shares fall despite the company posting better-than-expected quarterly profits and raising its full-year forecast. 4,333 -8.4% -397
Top 3 Products (Worldwide Sales 2007/08)
Annual Sales WW - Sales Growth per Year (%)
Rank1 Product Generic Name Therapeutic Subcategory 2007 2008 2008
1 Provigil modafinil Psychostimulants 8522 9883 +16%
2 Actiq fentanyl citrate Narcotic analgesics 3694 2725 -26%
3 Fentora fentanyl citrate Narcotic analgesics 1356 1557 +15%
Note: Shaded Cells8
RX Sales Chart
Cephalon Data Growth
2007 2008 2008
 Revenues By Segment
  Pharmaceuticals
     Pharmaceuticals Sales (In-depth)
       Rx & OTC Pharmaceuticals
         Prescription (Rx) Pharmaceuticals9 1,72710 1,94311   +13%  
Therapy Area Focus in 2008
Cephalon
2008
 WW Rx & OTC Sales By Therapy Area
  Main Categories
     Central Nervous System 1,493
     Musculoskeletal 74
     Oncology & Immunomodulators 100
     Other Rx & OTC Pharma 276
EvaluatePharma® Coverage of Marketed and Pipeline Products
Product Count
Cephalon 12 153

Register to access more FREE content:

  • 2009 Product Sales analysis
  • 2009 Pharmaceutical Sales
  • 2009 Market Share & Global Ranking
  • Download to Excel
  • Search 2 yrs of company press releases

 
EP Vantage - last 6 months
Event - Painful wait for ProStrakan on Abstral (August 16, 2010)
Court and FDA make for a bad day at Cephalon (March 30, 2010)